Shares of Bristol Myers Squibb BMY, +1.08% were down 2.5% in premarket trading on Wednesday after the company lowered guidance for earnings per share for the year. Bristol had earnings of $1.4 billion
Let's look what is in store for the four drug, biotech companies slated to release quarterly results tomorrow- BMY, GSK, ALKS, TEVA
Investors will likely focus on the demand for Eliquis and Opdivo along with incremental contribution from newer drugs when Bristol-Myers (BMY) reports Q2 results. Operating expenses might have jumped.
Investors seeking shelter from the market selloff through 2022 can take a look at some of the best cash cow stocks to buy. The post 7 Best Cash Cow Stocks to Buy for Stable Returns appeared first on I
The second-quarter earnings season is upon us, and the news coming out of several members of Big Pharma could potentially shake up their share prices. Beyond that, several unknowns could impact top-ti

Healthcare ETFs in Focus Ahead of Q2 Earnings

01:14pm, Thursday, 21'st Jul 2022
The healthcare sector has gained some momentum lately on investors' rush to safety in a volatile stock market. The sector is non-cyclical in nature, which in turn, is providing a cushion to the portfo

2 Rock-Solid Dividend Stocks to Buy Right Now

09:45am, Thursday, 21'st Jul 2022
These two dividend-paying pharmaceutical titans ought to keep crushing the broader markets for the foreseeable future.
The company is reshaping and expanding its oncology portfolio.

Get These 3 Juicy Dividend Yields While They Last

02:01am, Thursday, 21'st Jul 2022
A good strategy for this unprecedented backdrop may be to bunker down with steady dividend paying companies that are likely to trend higher as market conditions improve. Compared to what was available

7 Best Pharmaceutical Stocks to Buy Now

06:00pm, Wednesday, 20'th Jul 2022
These investments represent the best pharmaceutical stocks. Each offers incredible upside potential in the post-pandemic world.
Bristol Myers Squibb (NYSE: BMY) is scheduled to report its Q2 2022 results on Wednesday, July 27. We expect BMS to report revenue and earnings marginally above the consensus estimates.
After the first two quarters of fiscal year 2022, who holds the top spot in the InvestorPlace Best Stocks for 2022 contest? Let's dive in.
Multibillionaire investors are buying stocks at a discount. But they're selling some, too.

Best Stocks for 2022: Bristol-Myers Squibb

12:17pm, Friday, 08'th Jul 2022
BMY stock is up 21% this year. That's impressive compared to the market as a whole, which has entered bear territory, and it has room to grow.

6 Stocks Hedge Funds Love in a Recession

10:23am, Wednesday, 06'th Jul 2022
6 stocks hedge funds love in a recession, including the top 3 holdings from Michael Burry and Leon Cooperman. The post 6 Stocks Hedge Funds Love in a Recession appeared first on InvestorPlace.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE